Literature DB >> 17430415

Generalized anxiety disorder: a 40-year follow-up study.

G Rubio1, J J López-Ibor.   

Abstract

OBJECTIVE: There is insufficient knowledge of the long-term course of generalized anxiety disorder (GAD). We studied the course of this disorder in patients who were followed up for 40 years.
METHOD: Patients admitted with the diagnosis of anxiety states ('anxious thymopathy' ) to the Lopez Ibor Neuropsychiatric Research Institute between 1950 and 1961 were examined between 1984 and 1988 (n = 65). The retrospective diagnosis of GAD was made according to DSM-III-R criteria during 1984-1988 (first examination). A re-examination was performed by the same psychiatrist in the period 1997-2001 (n = 59; second examination).
RESULTS: At first and second examinations 20% and 17% of subjects were diagnosed as GAD. Improvement was observed in 83%. GAD tended to disappear around age 50, but was replaced by somatization disorders. Lack of regular treatment compliance, female sex, and onset of GAD before age 25 were variables associated with a worse outcome. Undifferentiated somatization disorder was the most prevalent clinical status at follow-up.
CONCLUSION: After several decades, participants improve with regard to GAD, although most continue to present somatizations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17430415     DOI: 10.1111/j.1600-0447.2006.00896.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  11 in total

1.  Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study.

Authors:  Julie Loebach Wetherell; Jill A Stoddard; Kamila S White; Sander Kornblith; Hoang Nguyen; Carmen Andreescu; Sidney Zisook; Eric J Lenze
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-27       Impact factor: 3.485

2.  Prevalence and correlates of somatoform disorders in the elderly: Results of a European study.

Authors:  Maria Christina Dehoust; Holger Schulz; Martin Härter; Jana Volkert; Susanne Sehner; Anna Drabik; Karl Wegscheider; Alessandra Canuto; Kerstin Weber; Mike Crawford; Alan Quirk; Luigi Grassi; Chiara DaRonch; Manuel Munoz; Berta Ausin; Anna Santos-Olmo; Arieh Shalev; Ora Rotenstein; Yael Hershkowitz; Jens Strehle; Hans-Ulrich Wittchen; Sylke Andreas
Journal:  Int J Methods Psychiatr Res       Date:  2017-02-01       Impact factor: 4.035

3.  Acceptance and Commitment Therapy for generalized anxiety disorder in older adults: a preliminary report.

Authors:  Julie Loebach Wetherell; Niloofar Afari; Catherine R Ayers; Jill A Stoddard; Joshua Ruberg; John T Sorrell; Lin Liu; Andrew J Petkus; Steven R Thorp; Alexander Kraft; Thomas L Patterson
Journal:  Behav Ther       Date:  2010-11-05

4.  Medical conditions and depressive, anxiety, and somatic symptoms in older adults with and without generalized anxiety disorder.

Authors:  Julie Loebach Wetherell; Catherine R Ayers; Roberto Nuevo; Murray B Stein; Joe Ramsdell; Thomas L Patterson
Journal:  Aging Ment Health       Date:  2010-08       Impact factor: 3.658

5.  The generalized anxiety spectrum: prevalence, onset, course and outcome.

Authors:  Jules Angst; Alex Gamma; David S Baldwin; Vladeta Ajdacic-Gross; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-24       Impact factor: 5.270

6.  The Relationship Between Generalized Anxiety Symptoms and Treatment Dropout Among Women in Residential Treatment for Substance Use Disorders.

Authors:  JoAnna Elmquist; Ryan C Shorey; Scott E Anderson; Gregory L Stuart
Journal:  Subst Use Misuse       Date:  2016-04-20       Impact factor: 2.164

7.  Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  Oriana Vesga-López; Franklin R Schneier; Samuel Wang; Richard G Heimberg; Shang-Min Liu; Deborah S Hasin; Carlos Blanco
Journal:  J Clin Psychiatry       Date:  2008-09-23       Impact factor: 4.384

8.  Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder.

Authors:  Juliana Belo Diniz; Dante Marino Malavazzi; Victor Fossaluza; Cristina Belotto-Silva; Sonia Borcato; Izabel Pimentel; Euripedes Constantino Miguel; Roseli Gedanke Shavitt
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Outcomes for depression and anxiety in primary care and details of treatment: a naturalistic longitudinal study.

Authors:  Marijn A Prins; Peter F M Verhaak; Mirrian Hilbink-Smolders; Peter Spreeuwenberg; Miranda G H Laurant; Klaas van der Meer; Harm W J van Marwijk; Brenda W J H Penninx; Jozien M Bensing
Journal:  BMC Psychiatry       Date:  2011-11-18       Impact factor: 3.630

Review 10.  Treatment of anxiety disorders.

Authors:  Borwin Bandelow; Sophie Michaelis; Dirk Wedekind
Journal:  Dialogues Clin Neurosci       Date:  2017-06       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.